ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
出版年份 2019 全文链接
标题
ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-12-27
DOI
10.1186/s13046-019-1506-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process
- (2019) Nadia Habel et al. BMC CANCER
- SS18-SSX-dependent YAP/TAZ Signaling in Synovial Sarcoma
- (2019) Ilka Isfort et al. CLINICAL CANCER RESEARCH
- Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
- (2019) Patrizia Nanni et al. Scientific Reports
- Connective tissue growth factor stimulates osteosarcoma cell migration and induces osteosarcoma metastasis by upregulating VCAM-1 expression
- (2018) Chun-Han Hou et al. BIOCHEMICAL PHARMACOLOGY
- Agave negatively regulates YAP and TAZ transcriptionally and post-translationally in osteosarcoma cell lines
- (2018) Maria Ferraiuolo et al. CANCER LETTERS
- Regulation of the Hippo pathway in cancer biology
- (2018) Sungho Moon et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Patient-derived xenograft models in musculoskeletal malignancies
- (2018) Wan Lu et al. Journal of Translational Medicine
- Hippo Signaling in the Immune System
- (2018) Yuchao Zhang et al. TRENDS IN BIOCHEMICAL SCIENCES
- Pazopanib in relapsed osteosarcoma patients: report on 15 cases
- (2018) Alessandra Longhi et al. ACTA ONCOLOGICA
- Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss)
- (2018) Stefano Ferrari et al. TUMORI
- Generation of patient‐derived tumor xenografts from percutaneous tumor biopsies in children with bone sarcomas
- (2018) Nino Rainusso et al. PEDIATRIC BLOOD & CANCER
- Orthotopic patient-derived xenografts of paediatric solid tumours
- (2017) Elizabeth Stewart et al. NATURE
- Pazopanib for second recurrence of osteosarcoma in pediatric patients
- (2017) Katsutsugu Umeda et al. PEDIATRICS INTERNATIONAL
- The Role and Clinical Significance of Yes-Associated Protein 1 in Human Osteosarcoma
- (2017) Y-H. Zhang et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- Metastatic osteosarcoma: a challenging multidisciplinary treatment
- (2016) Cristina Meazza et al. Expert Review of Anticancer Therapy
- Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma
- (2016) Corinne Bouvier et al. Oncotarget
- Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database
- (2015) Kyle R. Duchman et al. Cancer Epidemiology
- Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review)
- (2015) JUN LI et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
- (2015) Yangbo Feng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells
- (2015) Upal Basu-Roy et al. Nature Communications
- Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers
- (2015) Yusuke Oku et al. FEBS Open Bio
- The mammalian Hippo pathway: regulation and function of YAP1 and TAZ
- (2014) Manami Kodaka et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
- (2014) Katarzyna Brodowska et al. EXPERIMENTAL EYE RESEARCH
- YAP/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth
- (2014) Boon Chuan Low et al. FEBS LETTERS
- The Hippo pathway in chemotherapeutic drug resistance
- (2014) Yulei Zhao et al. INTERNATIONAL JOURNAL OF CANCER
- Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway
- (2014) Chun-Han Hou et al. Molecular Cancer
- YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
- (2014) Yan Xia et al. PLoS One
- Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
- (2014) M. Hidalgo et al. Cancer Discovery
- The CCN Family Proteins: Modulators of Bone Development and Novel Targets in Bone-Associated Tumors
- (2014) Po-Chun Chen et al. Biomed Research International
- Osteosarcoma treatment – Where do we stand? A state of the art review
- (2013) Anja Luetke et al. CANCER TREATMENT REVIEWS
- The Hippo pathway: regulators and regulations
- (2013) F.-X. Yu et al. GENES & DEVELOPMENT
- Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts
- (2013) Fernando Calvo et al. NATURE CELL BIOLOGY
- CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activity
- (2013) C Zucchini et al. ONCOGENE
- Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression
- (2013) L H Chan et al. ONCOGENE
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1
- (2012) Stefano Ferrari et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential Regulation of Adhesion Complex Turnover by ROCK1 and ROCK2
- (2012) Frances E. Lock et al. PLoS One
- Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage
- (2011) Guang Jian Liu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice
- (2011) Adam A Sabile et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Role of YAP/TAZ in mechanotransduction
- (2011) Sirio Dupont et al. NATURE
- YAP is a candidate oncogene for esophageal squamous cell carcinoma
- (2010) Tomoki Muramatsu et al. CARCINOGENESIS
- Prognostic Value of CCN3 in Osteosarcoma
- (2008) B. Perbal et al. CLINICAL CANCER RESEARCH
- Therapy for Osteosarcoma
- (2008) Alexander J Chou et al. PEDIATRIC DRUGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More